Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 8.14% | -0.29% | -0.29% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 8.14% | -0.29% | -0.29% |
Source Capital delivered a -0.29% quarterly return but gained 16.01% over the trailing twelve months, outperforming its balanced benchmark. The fund maintains a nearly balanced allocation between equities (43.6%) and credit (31.3%), with 21% in cash. Top equity performers included Alphabet, Analog Devices, and Citigroup, while bottom performers were led by Comcast and Aon. The managers are actively harvesting gains from long-held positions like Kinder Morgan and Swire Pacific, recycling proceeds into undervalued opportunities in SMID caps, international names, and healthcare. They added to positions in Azelis and Becton Dickinson during the quarter. Private credit represents 26.1% of committed capital with plans to increase exposure. AI fears impacted software debt spreads, creating potential opportunities given the fund's limited software exposure. The team is evaluating opportunities across sectors where valuations have become more reasonable, building positions in several names while maintaining their disciplined value approach.
Source Capital employs a balanced approach between equities and credit, focusing on harvesting gains from long-held positions and recycling proceeds into undervalued opportunities in SMID caps, international names, and healthcare while expanding private credit exposure.
The team is busy evaluating opportunities in several sectors where valuations are more reasonable than they were a year ago. They are building positions in several names and look forward to providing more details in their midyear letter.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| May 6 2026 | 2026 Q1 | ADI, AON, BDX, CHTR, CMCSA, FBHS, GLEN.L, GOOGL, KMI, KMX, TEL | Balanced, healthcare, international, private credit, SMID Cap, value | - | Source Capital outperformed with 16% annual returns despite a flat quarter, maintaining balanced equity-credit allocation. Managers harvest gains from decade-long holdings, recycling into undervalued SMID caps, international names, and healthcare. Expanding private credit to 26% while AI fears create software opportunities. Building new positions as valuations improve across sectors. |
| Feb 10 2026 | 2025 Q4 | ADI, CRM, GOOGL, IFF, META, MSFT, MTN, NOW, NTDOY, ORCL, SAF.PA, SAP, SNOW, TEL, WDAY | Balanced, credit, private credit, Quality, small caps, value |
TEL SAF FP IFF MTN MSFT |
Source Capital's value-aware approach delivered 18.38% trailing returns by finding quality at attractive prices. The fund is reducing high yield exposure due to historically low credit spreads while increasing private credit allocation. Focus remains on overlooked global small-caps offering asymmetric risk-reward, with successful holdings like TE Connectivity and Safran demonstrating the strategy's effectiveness in patient, disciplined value investing. |
| Nov 27 2025 | 2025 Q3 | C, CMCSA, GLEN.L, GOOGL, IFF, JDEPY, KMX, PRX, RI.PA, TE | Balanced, credit, equities, global, value |
IFF KMX |
Source Capital delivered strong quarterly and annual returns through balanced equity-credit positioning. Top performers Citigroup and Alphabet drove gains while CarMax disappointed due to management execution issues. Managers avoided expensive high-yield credit markets but continue expanding private credit exposure. The fund maintains disciplined global approach with 5.55% distribution rate. |
| Aug 14 2025 | 2025 Q2 | ABBV, ABT, ACLX, ARGX, AZN, BSX, CDTX, COO, HRTX, IMVT, INSM, IONS, ISRG, JNJ, LLY, MASI, MDT, PFE, RDNT, ROIV, SYK, TMO, UNH, WAT, XEN.TO | AI, Biotechnology, GLP1, healthcare, Managed Care, Medical Devices, Pharmaceuticals | - | Baron Health Care Fund delivered 5.39% returns in Q3 2025, driven by strong biotechnology stock selection, particularly argenx and Insmed benefiting from drug approvals. AI-enabled healthcare solutions like RadNet and Heartflow also contributed. Despite regulatory headwinds and hospital financial pressures, the fund maintains conviction in secular healthcare growth from aging demographics and technological innovation. |
| May 14 2025 | 2025 Q1 | 005930.KS, 012330.KS, CNQ, FOXA, GOOGL, MSFT, PEP, PG, SCHW, UHAL | AI, Cyclical, large cap, risk management, semiconductors, valuation, value |
005930.KS BOL.PA UHAL |
Yacktman Fund underperformed in Q3 but maintains value discipline amid expensive market valuations and multiple risk factors. Samsung's Nvidia HBM design win validates AI positioning while Bolloré's simplification story remains intact despite near-term weakness. With 30+ years navigating cycles, managers believe portfolio is positioned for strong risk-adjusted returns during eventual market corrections. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
Private CreditSource has 26.1% committed to private credit including called and uncalled capital as of quarter-end. The fund continues to look for opportunities to increase that exposure. |
Private Credit Alternative Credit Direct Lending |
AIFears of artificial intelligence decimating the profitability of many software companies caused spreads on associated debt to increase. The capabilities of artificial intelligence are progressing rapidly and some software companies may become casualties of this new technology. |
Artificial Intelligence Software Technology | |
ValueThe team is busy evaluating opportunities in several sectors where valuations are more reasonable than they were a year ago. They are harvesting gains from long-held positions and recycling proceeds into what they perceive to be undervalued opportunities, namely SMID caps, international names, and healthcare. |
Value Investing Undervalued Opportunistic | |
| 2025 Q4 |
Behavioral FinanceManager extensively discusses behavioral biases in investing, comparing rational 'Morning Investor' mode to impulsive 'Nighttime Investor' decisions. Emphasizes the importance of overcoming psychological biases like avoiding action that could cause regret, and building habits to make better investment decisions. |
Behavioral Biases Psychology Decision Making |
ValueMature (Value) businesses led performance in Q4 and were the strongest contributors for the full year, reflecting durable execution in companies generating healthy free cash flow and returning capital. The strategy maintains exposure to value-oriented businesses as part of its diversified approach. |
Free Cash Flow Capital Return Mature Businesses | |
GrowthEmerging (Growth) businesses reversed some substantial gains in Q4 but delivered a strong year overall, generating significant alpha relative to the benchmark. Despite Q4 weakness, the growth basket contributed meaningfully to annual performance. |
Alpha Generation Emerging Businesses | |
| 2025 Q3 |
Private CreditSource has 25.6% committed to private credit including called and uncalled capital as of quarter-end. The fund continues to look for opportunities to increase that exposure. |
Private Credit Alternative Credit Direct Lending |
Credit StressHigh-yield market was historically expensive with spreads at third percentile. Low spreads expose investors to risk of uncompensated losses from credit-related impairments and greater mark-to-market losses when bonds reprice to wider spreads. |
Credit Spreads High Yield Credit Risk | |
AIAlphabet continues to enhance its existing search offering with new AI features that have been well-received and are continually evolving. Recent concerns include competitive threats in search stemming from competing AI models. |
Artificial Intelligence Search Technology | |
| 2025 Q2 |
BiotechnologyStrong stock selection in biotechnology contributed the vast majority of relative gains, with main drivers being argenx SE and Insmed Incorporated. The quarter saw several positive biotechnology clinical data readouts, a strong rebound in biotechnology funding, and an acceleration in M&A activity. |
FcRn inhibitors Autoimmune Pulmonary diseases Clinical trials Drug approvals |
AIAI-driven solutions are having significant benefits on healthcare operations, particularly in diagnostic imaging. RadNet benefits from AI capabilities and operational scale, while Heartflow's AI algorithm improves with scale and data, enabling margin expansion as the company reduces employee hours in real-time workflows. |
Medical imaging Diagnostic accuracy Workflow automation Margin expansion Scale benefits | |
GLP1Long term, the GLP-1 drug class is expected to become the standard of care for diabetes and obesity, ultimately representing a $150 billion-plus market. Lilly possesses the leading portfolio in this category, with GLP-1 adoption remaining in the early stages and continued uptake expected to drive a near doubling of Lilly's total revenues by 2030. |
Diabetes Obesity Standard of care Market expansion Revenue growth | |
Managed CareUnitedHealth Group represents a leading managed health care company with competitive advantages including scale, data, vertical integration with service providers, and leadership in Medicare Advantage and value-based care. The company trades at close to a 10-year low relative valuation with potential for valuation expansion. |
Medicare Advantage Value-based care Vertical integration Scale advantages Medical cost trends | |
| 2025 Q1 |
ValueThe fund seeks opportunities where company value is misunderstood and price fairly compensates for risks. They carefully consider price paid for investments and focus on companies trading at attractive valuations relative to intrinsic worth. |
Valuation Mispricing Risk-adjusted Intrinsic Discount |
AISamsung achieved first design win with Nvidia for high bandwidth memory chips, validating its position in the AI-driven HBM chip market. Alphabet has participated in the AI frenzy despite longer-term risks to advertising revenue. |
HBM Memory Nvidia Data Centers Semiconductors | |
SemiconductorsSamsung was late to the AI party but achieved milestone with Nvidia HBM design win. Memory chips are found across vast array of end products from data centers to automobiles. Finite production capacity exists for DRAM with small number of capable players. |
Memory DRAM Fabrication Samsung Capacity | |
Risk AppetiteThe fund constantly considers what could go wrong and evaluates companies across economic cycles. They believe current environment is full of risks including geopolitical, regulatory, leverage, supply chain, and tariffs. Market remains momentum-driven with expensive valuations. |
Downside Cycles Momentum Valuations Geopolitical |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Fund Letters | Mark Landecker | TEL | TE Connectivity plc | Information Technology | Electronic Components | Bull | New York Stock Exchange | Acquisitions, Automation, cashflow, Connectivity, data centers, dividends, Grid, reliability, Sensors | Login |
| Feb 10, 2026 | Fund Letters | Mark Landecker | SAF FP | Safran SA | Industrials | Aerospace & Defense | Bull | Euronext Stock Exchange | Aerospace, aftermarket, Air Traffic, Cyclical, efficiency, Engines, guidance, Maintenance, Margins | Login |
| Feb 10, 2026 | Fund Letters | Mark Landecker | IFF | International Flavors & Fragrances Inc. | Materials | Specialty Chemicals | Bull | New York Stock Exchange | cashflow, deleveraging, divestitures, Governance, Ingredients, leverage, Margins, Multiples, turnaround | Login |
| Feb 10, 2026 | Fund Letters | Mark Landecker | MTN | Vail Resorts, Inc. | Consumer Discretionary | Leisure Facilities | Bull | New York Stock Exchange | Cyclical, inflation, Labor, leverage, Margins, seasonality, valuation, Visitation, Weather | Login |
| Feb 10, 2026 | Fund Letters | Mark Landecker | MSFT | Microsoft Corporation | Information Technology | Systems Software | Bear | NASDAQ | AI, cloud, Expectations, growth, Multiples, Platforms, TAM, valuation, Workflows | Login |
| Nov 27, 2025 | Fund Letters | Mark Landecker | IFF | International Flavors & Fragrances Inc. | Materials | Materials | Bull | NYSE | cashflow, deleveraging, Ingredients, Margins, restructuring, specialty, turnaround, valuation | Login |
| Nov 27, 2025 | Fund Letters | Mark Landecker | KMX | CarMax, Inc. | Consumer Discretionary | Consumer Discretionary | Bull | NYSE | Autos, Credit, Cyclical, Execution, leverage, Margins, retail, valuation | Login |
| Sep 30, 2025 | Fund Letters | FPA Source Capital | 005930.KS | Samsung Electronics Co Ltd | Information Technology | Semiconductors & Semiconductor Equipment | Bull | Korea Stock Exchange | Artificial Intelligence, DRAM, Geographic Diversification, HBM, memory chips, NVIDIA, oligopoly, Semiconductor Fabrication, semiconductors, South Korea | Login |
| Sep 30, 2025 | Fund Letters | FPA Source Capital | BOL.PA | Bollore SE | Communication Services | Media | Bull | Euronext Paris | Asset Simplification, balance sheet improvement, conglomerate, discount to NAV, media, net asset value, Structural Transformation, Universal Music Group, value unlocking, Vivendi | Login |
| Sep 30, 2025 | Fund Letters | FPA Source Capital | UHAL | U-Haul Holding Company | Industrials | Commercial Services & Supplies | Bull | NASDAQ | Analyst Coverage Gap, capital allocation, Cash Flow Reinvestment, Dual Business Model, long-term investment, recurring revenue, REIT Economics, Sector Misclassification, Self-storage, Truck Rental | Login |
| TICKER | COMMENTARY |
|---|---|
| GOOGL | Alphabet contributed 1.94% to the Fund's return over the trailing twelve months. |
| ADI | Analog Devices contributed 1.25% to the Fund's return over the trailing twelve months. |
| TEL | TE Connectivity contributed 1.03% to the Fund's return over the trailing twelve months. |
| GLEN.L | Glencore functions as one of the largest mining and trading operations in the world, highly leveraged to materials like copper, zinc, and coal, which spiked amid supply disruptions and strong global demand. Shares of Glencore stock rose after reports of a potential merger with Rio Tinto, which subsequently failed to materialize. The company later announced it would return $2 billion to shareholders through cash distributions, following ongoing share repurchases throughout most of 2025. |
| CMCSA | Comcast detracted -0.29% from the Fund's return over the trailing twelve months. |
| AON | Longtime holding Aon is among the world's leading providers of insurance/reinsurance brokerage and human resources solutions. The company reported slowing organic revenue growth for 2025, which led to a slew of sell-side downgrades that pressured the stock price. Aon currently trades at an undemanding multiple of earnings and maintains a long track record of opportunistic acquisitions that have created value for shareholders over time. |
| CHTR | Charter Communications detracted -0.28% from the Fund's return over the trailing twelve months. |
| FBHS | Fortune Brands detracted -0.25% from the Fund's return over the trailing twelve months. |
| KMX | CarMax detracted -0.23% from the Fund's return over the trailing twelve months. |
| BDX | During the past quarter our two largest purchases were additions to existing positions - Azelis, a small-cap, European-based specialty chemical distributor, and Becton Dickinson, a US-based medical technology company. |
| KMI | In contrast our two largest sales were Kinder Morgan and Swire Pacific, positions we have held for well over a decade. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||